Foveal thinning in neuromyelitis optica
A sign of retinal astrocytopathy?
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published April 11, 2017.
Author Disclosures
- Takashi Yamamura, MD, PhD and
- Ichiro Nakashima, MD, PhD
- Takashi Yamamura, MD, PhD and
(1)Biogen Japan (2) Chugai Pharmaceutical Co., Ltd (3) Takeda Pharamaceutical Co.
NONE
(1) Novartis Pharma (2) Nihon Pharmaceutical Co., Ltd., (3) Santen Pharmaceutical Co., Ltd., (4) Abbott Japan Co., Ltd./Eisai Co., Ltd., (5) Biogen Japan, (6) Dainippon Sumitomo Pharma Co., Ltd., (7) Bayer Holding Ltd., (8) Astellas Pharma Inc. (9) Takeda Pharamaceutical Co.
Clinical and Experimental Neuroimmunology, Editor, since 2010
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Ono Pharmaceutical Co., Ltd., (2) Chugai Pharmaceutical Co., Ltd., (3) Teva Pharmaceutical K.K., (4) Mitsubishi Tanabe Pharma Corporation, (5) Asahi Kasei Kuraray Medical CO., Ltd.
(1) Ministry of Health, Labour and Welfare of Japan, the Health and Labour Sciences Research Grants on Intractable Diseases (Neuroimmunological Diseases), investigator, since 2010.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ichiro Nakashima, MD, PhD
NONE
NONE
Received funding for a trip and speaks from Mitsubishi Tanabe Pharma (2012-2016) and Novartis Pharma (2012-2015).
Served as an editorial board member of Multiple Sclerosis International(2010-present).
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Received grant support from LSI Medience Corporation (2012-2016).
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the National Institute of Neuroscience (T.Y.), NCNP, Kodaira, Tokyo; and Department of Neurology (I.N.), Tohoku University School of Medicine, Aoba-ku, Sendai, Japan.
- Correspondence to Dr. Yamamura: yamamura{at}ncnp.go.jp
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Article
Optical coherence tomography is highly sensitive in detecting prior optic neuritisSarah Chaoying Xu, Randy H. Kardon, Jacqueline A. Leavitt et al.Neurology, January 23, 2019 -
Article
In vivo identification of morphologic retinal abnormalities in neuromyelitis opticaElias S. Sotirchos, Shiv Saidha, Gita Byraiah et al.Neurology, March 20, 2013 -
Article
Microstructural visual system changes in AQP4-antibody–seropositive NMOSDFrederike C. Oertel, Joseph Kuchling, Hanna Zimmermann et al.Neurology: Neuroimmunology & Neuroinflammation, February 22, 2017 -
Article
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritisSudarshini Ramanathan, Stephen W. Reddel, Andrew Henderson et al.Neurology - Neuroimmunology Neuroinflammation, October 29, 2014